Literature DB >> 3525339

Gut endocrine cell population in coeliac disease estimated by immunocytochemistry using a monoclonal antibody to chromogranin.

R Pietroletti, A E Bishop, F Carlei, M Bonamico, R V Lloyd, B S Wilson, A Ceccamea, E Lezoche, V Speranza, J M Polak.   

Abstract

Abnormalities of gut endocrine responses, as well as changes in the number of different endocrine cell types, have been reported convincingly in coeliac patients. Nevertheless, no estimation of total numbers of gut endocrine cells has yet been made in well defined groups of coeliacs. In this study, we have visualised all endocrine cell types in jejunal biopsies from coeliac patients with active and quiescent disease as well as in controls, using a monoclonal antibody to chromogranin. This protein was purified originally from bovine adrenal medulla and is known to be a reliable marker for all endocrine cells of the gut. The following groups were considered: (a) nine coeliacs with active illness, (b) 10 coeliacs under gluten-free diet, (c) eight coeliacs receiving gluten challenge, (d) five non-coeliacs (controls). Histological (haematoxylin and eosin) and immunocytochemical (peroxidase anti-peroxidase) stains were applied to 3 micron paraffin sections. Quantitative estimation of endocrine cell density was made using four different methods in order to evaluate the results fully (number of cells/mm2, number of cells/visual field, number of cells/8 crypts-villi, number of cells/unit of length of muscularis mucosae). In patient groups (a) and (c), coeliacs with active disease and coeliacs on gluten challenge diet respectively, a significantly higher number of endocrine cells was observed in comparison with normal controls (group d). In group (b) patients, coeliacs on gluten-free diet, no significant changes in the number of endocrine cells were observed in comparison with controls. Our results show that a significant increase in endocrine cell density exists in coeliacs with active illness (groups a and c), in comparison with controls. This condition is resolved in coeliacs receiving a gluten-free diet (group b).

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3525339      PMCID: PMC1433562          DOI: 10.1136/gut.27.7.838

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  19 in total

1.  Enterocyte in coeliac disease. 1.

Authors:  C C Booth
Journal:  Br Med J       Date:  1970-09-26

2.  Chromogranin: a newly recognized marker for endocrine cells of the human gastrointestinal tract.

Authors:  P Facer; A E Bishop; R V Lloyd; B S Wilson; R J Hennessy; J M Polak
Journal:  Gastroenterology       Date:  1985-12       Impact factor: 22.682

3.  Impaired immunoreactive secretin release in coeliac disease.

Authors:  F A O'Connor; J C McLoughlin; K D Buchanan
Journal:  Br Med J       Date:  1977-03-26

4.  Gut-hormone profile in coeliac disease.

Authors:  H S Besterman; S R Bloom; D L Sarson; A M Blackburn; D I Johnston; H R Patel; J S Stewart; R Modigliani; S Guerin; C N Mallinson
Journal:  Lancet       Date:  1978-04-15       Impact factor: 79.321

5.  Secretion from the adrenal medulla: biochemical evidence for exocytosis.

Authors:  F H Schneider; A D Smith; H Winkler
Journal:  Br J Pharmacol Chemother       Date:  1967-09

6.  Secretin cells in coeliac disease.

Authors:  J M Polak; A G Pearse; S Van Noorden; S R Bloom; M A Rossiter
Journal:  Gut       Date:  1973-11       Impact factor: 23.059

7.  Purification and properties of an acidic protein from chromaffin granules of bovine adrenal medulla.

Authors:  A D Smith; H Winkler
Journal:  Biochem J       Date:  1967-05       Impact factor: 3.857

8.  Duodenal endocrine cells in adult coeliac disease.

Authors:  K Sjölund; J Alumets; N O Berg; R Håkanson; F Sundler
Journal:  Gut       Date:  1979-07       Impact factor: 23.059

9.  Studies of intestinal lymphoid tissue. III. Quantitative analyses of epithelial lymphocytes in the small intestine of human control subjects and of patients with celiac sprue.

Authors:  M N Marsh
Journal:  Gastroenterology       Date:  1980-09       Impact factor: 22.682

10.  Enteropathy of coeliac disease in adults: increased number of enterochromaffin cells the duodenal mucosa.

Authors:  K Sjölund; J Alumets; N O Berg; R Håkanson; F Sundler
Journal:  Gut       Date:  1982-01       Impact factor: 23.059

View more
  11 in total

Review 1.  Impaired intestinal cholecystokinin secretion, a fascinating but overlooked link between coeliac disease and cholesterol gallstone disease.

Authors:  Helen H Wang; Min Liu; Xiaodan Li; Piero Portincasa; David Q-H Wang
Journal:  Eur J Clin Invest       Date:  2017-03-08       Impact factor: 4.686

2.  Editorial: fecal granins in IBS: cause or indicator of intestinal or colonic irritation?

Authors:  Michael Camilleri
Journal:  Am J Gastroenterol       Date:  2012-03       Impact factor: 10.864

3.  Increased populations of endocrine cells in Crohn's ileitis.

Authors:  A E Bishop; R Pietroletti; C W Taat; W H Brummelkamp; J M Polak
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1987

4.  Lack of endogenous cholecystokinin promotes cholelithogenesis in mice.

Authors:  H H Wang; M Liu; P Portincasa; P Tso; D Q-H Wang
Journal:  Neurogastroenterol Motil       Date:  2015-11-25       Impact factor: 3.598

5.  The ghrelin-positive cells number is increased in duodenum in children with celiac disease.

Authors:  E Jarocka-Cyrta; I Kasacka; M Kaczmarski
Journal:  J Endocrinol Invest       Date:  2009-09-30       Impact factor: 4.256

Review 6.  Physiological underpinnings of irritable bowel syndrome: neurohormonal mechanisms.

Authors:  Michael Camilleri
Journal:  J Physiol       Date:  2014-03-24       Impact factor: 5.182

7.  Poorly differentiated neuroendocrine rectal carcinoma with uncommon immune-histochemical features and clinical presentation with a subcutaneous metastasis, treated with first line intensive triplet chemotherapy plus bevacizumab FIr-B/FOx regimen: an experience of multidisciplinary management in clinical practice.

Authors:  Gemma Bruera; Antonio Giuliani; Lucia Romano; Alessandro Chiominto; Alessandra Di Sibio; Stefania Mastropietro; Pierluigi Cosenza; Enrico Ricevuto; Mario Schietroma; Francesco Carlei
Journal:  BMC Cancer       Date:  2019-10-16       Impact factor: 4.430

8.  Simultaneous analyses of carbohydrate-mediated serum GLP-1 and GLP-2 and duodenal receptor expression in children with and without celiac disease.

Authors:  Marianna Rachmiel; Gilad Ben-Yehudah; Haim Shirin; Efrat Broide
Journal:  Therap Adv Gastroenterol       Date:  2019-04-17       Impact factor: 4.409

Review 9.  The relation between celiac disease, nonceliac gluten sensitivity and irritable bowel syndrome.

Authors:  Magdy El-Salhy; Jan Gunnar Hatlebakk; Odd Helge Gilja; Trygve Hausken
Journal:  Nutr J       Date:  2015-09-07       Impact factor: 3.271

Review 10.  The chromogranins A and B: the first 25 years and future perspectives.

Authors:  H Winkler; R Fischer-Colbrie
Journal:  Neuroscience       Date:  1992-08       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.